Radioembolization is an established treatment modality that has been subjected to many
improvements over the last decade. Developments are occurring at a high pace, affecting …

Radioembolization gains continuous traction as a primarily palliative radiation treatment for
hepatic tumours. A form of nuclear medicine therapy, Yttrium-90 containing microspheres …

Radioembolisation is a locoregional treatment modality for hepatic malignancies. It consists
of several stages that are vital to its success, which include a pre-treatment angiographic …

In recent years, yttrium-90 (90Y) microsphere radioembolization has been establishing itself
as a safe and efficacious treatment for both primary and metastatic liver cancers. This …

Abstract Purpose 90 Y-radioembolization (RE) is a promising technique for delivering high
doses of radiation to liver tumors but may result in compromise of liver function. To gain …

Radioembolization is a widely used treatment for non-resectable primary and secondary
liver cancer. This handbook addresses the radiation biology, physics, nuclear medicine, and …

Radioembolization (RE) is an emerging treatment strategy for patients with primary hepatic
malignancies and metastatic liver disease. Though RE is primarily performed in the …

The purpose of this study was to assess the safety of repeated 90Y radioembolization with
resin microspheres in patients with extensive primary and secondary liver tumors after …

Purpose Repeated radioembolization (RE) treatments carry theoretically higher risk of
radiation-induced hepatic injury because of the liver's cumulative memory of previous …

The incidence of hepatocellular carcinoma is increasing. Most patients present beyond
potentially curative options and are usually affected by underlying cirrhosis. In this scenario …